Protein kinases are an important class of substrate of the protein phosphatases. We have examined the mechanism of dephosphorylation of the activation segments of the insulin receptor kinase and cyclin-dependent kinase 2 by their respective phosphatases, namely the tyrosine specific phosphatase P T P l B and the dual specificity phosphatase KAP. These studies reveal that P T P l B and KAP utilize contrasting mechanisms in order to dephosphorylate their substrates specifically.
Introduction
The regulation of cellular processes by reversible protein phosphorylation is diverse and ubiquitous. The overall level of protein phosphorylation is controlled by the opposing and dynamic activities of protein kinases and phosphatases that catalyse protein phosphorylation and dephosphorylation events respectively. Insights into the regulation and specificity of the reactions catalysed by protein kinases and phosphatases are the key to understanding the process of protein phosphorylation. Many protein kinases are themselves regulated by phosphorylation, either resulting from autophosphorylation or by the actions of upstream kinases. Protein kinases therefore form an important class of substrates of the protein phosphatases. By dephosphorylating protein kinases, a protein phosphatase is capable of exerting both acute and global changes in the levels of protein phosphorylation. Similar to the regulation of other phosphoproteins, dephosphorylation of protein kinases results in either their activation or inactivation. A general mechanism for the regulation of protein kinases is the reversible phosphorylation of residues within the activation segment of the kinase ~~ Key words: dual specificity protein phosphatases (DSPs), insulin receptor, insulin receptor kinase (IRK), kinase-associated phosphatase (KAP), phosphoproteins, protein tyrosine phosphatase I B (PTP I 6). Abbreviations used: PTP, protein tyrosine phosphatase; DSP. dual specificity protein phosphatase; IR(K), insulin receptor (kinase); KAP, kinase-associated phosphatase: CDU, cyclin-dependent kinase 2 : PTK protein tyrosine kinase: EGFR epidermal growth factor receptor. 'e-mail dbarford@icr.ac.uk [l] . Phosphorylation of residues within the activation segment is associated with an increase in kinase activity and therefore protein phosphatasecatalysed dephosphorylation at these sites is generally associated with negative regulation of a protein phosphorylation cascade.
The protein phosphatases are encoded by three major families, which include the serine/ threonine protein phosphatases of the PPP and PPM families [2, 3] and the protein tyrosine phosphatase (PTP) superfamily. The conventional PTPs are specific for the dephosphorylation of phosphotyrosine (pTyr)-containing proteins; however, a subfamily of the PTPs, termed the dual specificity protein phosphatases (DSPs), are characterized by their ability to dephosphorylate all three major phospho-amino acids of eukaryotic cells. T o obtain insights into the mechanisms by which protein phosphatases regulate protein kinases, we have determined the structures of protein phosphatases in complex with phospho-protein kinase substrates. First, we have determined the structure of the protein tyrosine phosphatase P T P l B in complex with a pTyr-containing peptide derived from the activation segment of the insulin receptor (IR) kinase (IRK) and, secondly, we have determined the structure of a complex formed between the DSP called KAP (kinase--associated phosphatase; also termed Cdil , Cip2) and phospho-cyclin-dependent kinase 2 (CDK2).
In this paper I compare and contrast the mechanism of dephosphorylation of pTyr-containing substrates by the PTPs, exemplified by the P T P l B-catalysed dephosphorylation of the activation segment of the IRK, with that of the DSP KAP-mediated dephosphorylation of pThr'" of CDK2.
PTP I B-IRK complex
Insulin signalling pathways initiate at the IR, which is comprised of two extracellular a-subunits and two transmembrane P-subunits. Activation of the receptor results in the autophosphorylation of both P-subunits on tyrosine residues. The major sites of autophosphorylation within the protein tyrosine kinase (PTK) domain of the P-subunit are Tyr'l'', Tyr116' and Tyr11B3 [4] , which are con-tained within the P T K activation segment [S] . Autophosphorylation of all three sites is required for maximal activation [S] . Following activation, additional autophosphorylation reactions occur in the juxtamembrane segment and the C-terminal tail of the p-subunit [S] .
Much preliminary data have implicated P T P l B in the regulation of IR signalling. Microinjection of purified PTPl B into Xenopus oocytes inhibited insulin-induced activation of S6 kinase and transition through the G,/M-phase checkpoint. When overexpressed in Rat1 fibroblasts expressing the IR, P T P l B inhibited hormoneinduced phosphorylation of the IR and downstream substrates, and inhibited hormoneinduced incorporation of glucose into glycogen [6] . Furthermore, osmotic loading of neutralizing antibodies against PTPl B into hepatoma cells enhanced both insulin-induced receptor autophosphorylation and phosphorylation of the IR substrate IRS-1, suggesting a direct effect of the phosphatase on the IR [7] . Such direct effects were also supported by the demonstration of association between inactive Cys-Ser mutant forms of PTPlB, which may serve as substrate 'traps', and the IR [8] . T h e most compelling data implicating P T P l B as the IRK phosphatase were established from the studies of P T P l B knock-out mice.
Disruption of the PTPlB gene yielded healthy mice that displayed enhanced sensitivity to insulin [9] . When fed a high-fat diet, the P T P l B knockout mice were resistant to becoming obese and remained insulin-sensitive, in contrast with their normal littermates, who displayed a rapid gain of weight and insulin resistance. These effects were correlated with enhanced tyrosine phosphorylation of the IR in the PTPl B-'-animals. Together, these data illustrate that the IR is an important physiological substrate of P T P l B, and identify this phosphatase as a novel therapeutic target for the treatment of diabetes and obesity.
T o understand how P T P l B dephosphorylates the IRK, we co-crystallized P T P l B in the presence of a series of pTyr peptides corresponding to the activation segment of the kinase [lo] . T h e general features of all IRK phosphopeptides bound to P T P l B are similar to those of the previously determined epidermal growth factor receptor (EGFR) peptide-PTPlB complex [ll] . T h e catalytic site of PTPl B is formed from a cleft on the protein's molecular surface. The base of the cleft comprises residues of the conserved P T P signature motif (referred to as the P T P loop), with the phosphate group of the substrate co-ordinated by main-chain amide groups and the side chain of the ArgZZ1 residue in this motif. Within the signature motif, the invariant cysteine residue (Cys215) is positioned to function in a nucleophilic attack on the phosphate moiety of the substrate. T h e depth of the cleft is determined by an invariant tyrosine, Tyr4', from the pTyr-recognition loop, which is a major determinant of specificity for pTyr. Binding of substrate induces a conformational change in the protein in which the W P D loop (residues 179-1 87), containing the invariant aspartate residue (Asp'"), closes around the substrate to create the pTyr recognition pocket and generates the catalytically competent form of the enzyme. Engagement of the pTyr residue in the substrate involves a number of hydrophobic interactions between the phenyl group of the pTyr residue and residues lining the cleft, which anchors the peptide to the substrate-binding site. T h e IRK peptide binds to P T P l B with an orientation perpendicular to the parallel region of the central p-sheet, with residues of the peptide flanking the substrate pTyr residue adopting an extended p-strand conformation (Figure 1) .
A feature of the pTyr-substrate recognition by P T P l B is the nature of the extensive contacts formed between the enzyme, the pTyr-substrate residue and residues on the peptide that flank the pTyr residue. T h e bisphosphopeptide, which is phosphorylated on tyrosines corresponding to Tyr11B2 and Tyr11B3 in the IR activation segment sequence, interacts with P T P l B in a defined manner, such that pTyr11B2 is located at the catalytic site, indicating a substrate selectivity for pTyr11B2 relative to pTyr11B3 (Figure 1 ). This mode of peptide recognition results from the extensive and specific P T P l B-peptide interactions involving residues both N-and C-terminal to the substrate pTyr residue, in particular AspllS1, pTyr'ls3 and Arg11B4. T h e pTyr residue at the catalytic site (pTyr"") interacts with P T P l B in a manner identical with that observed for the pTyr residue in the EGFR peptide-PTPlB complex [ll] . T h e phenyl ring of pTyr'162 is sandwiched between the aromatic side chains of Tyr4' and PhelS2 (Figure 1 ). Bidentate hydrogen bonds between the carboxylate side chain of Asp4' and the peptide amide (-NH) groups of pTyr11B2 and pTyr'lB3 (P+ 1) are important in orientating the peptide.
The second pTyr residue of the peptide, pTyr11s3 (P+ l), is located within a shallow groove on the protein surface connected via a channel to the catalytic pTyr-binding cleft. Interactions be-tween ~T y r l '~~ and the protein are dominated by the salt bridges between its phosphate group and the side chains of ArgZ4 and Arg254 of PTPlB, an invariant residue in the PTP family. The phenyl ring of pTyr11s3 participates in long contacts with the amide side chain of GlnZ6' and the side chain of Met2". T h e specificity of this site for a pTyr residue C-terminal to the substrate pTyr, rather than the shorter pSer and pThr residues, is primarily due to the length of pTyr, which is the correct size to allow its phosphate group to reach ArgZ4 and ArgZ5'. T h e presence of a glycine residue at position 259 is a critical structural feature of this site in P T P l B that allows an interaction with a bulky pTyr residue. Amino acids with more bulky side chains would sterically hinder these interactions.
In addition to interactions involving the tandem pTyr residues, the bisphosphorylated peptide also makes several other interactions with PTPlB. First, N-terminal to the substrate pTyr residue, the carboxylate group of Asp"" (P-1) of the IR peptide accepts a hydrogen bond from the guanidinium group of Argg7 of PTPlB. This interaction is responsible for the preference of P T P l B towards peptides with acidic residues Nterminal to the substrate pTyr residue. Similar interactions were observed between the glutamate (P-1) and aspartate (P-2) residues of the EGFR peptide in complex with P T P l B [ll], although the conformation of the Argg7 side chain differs between the two complexes.
A distinguishing feature of the bisphosphopeptide-PTP1 B complex is the presence of peptide-protein interactions involving residues Cterminal to the substrate pTyr. In addition to ~T y r "~~ ( P + l ) , residues at P + 2 and P + 4 also interact with the protein. The P + 2 residue is Arg1I6', and its guanidinium side chain forms a classic n-cation interaction with the phenyl ring of PhelEZ of the WPD loop (Figure 1 ). T h e guanidinium group of Arg116' is positioned parallel to the phenyl ring of Phe"', a geometry that is preferred in protein structures. T h e Arg-Phe interaction illustrates the concerted character of the peptideprotein interactions, in that it requires the WPD loop to adopt the closed conformation that is induced by the interaction of the substrate pTyr residue at the catalytic site.
The structural data presented here, which indicate that P T P l B recognizes tandem pTyr residues via interactions that principally involve the phosphate group of the P + 1 pTyr residue, are consistent with kinetic data showing that peptides phosphorylated on both Tyr"62 and T Y~" '~ bind to P T P l B with ~1 0 0 -f o l d higher affinity than peptides singly phosphorylated on Tyr"" or Tyr11s3 alone [lo] . Examination of the sequences of other PTPs in the context of the PTPlB-IRK interactions defined by the P T P l B-IRK structure provides insights concerning the specificity of this interaction. As expected, residues of P T P l B that interact with the pTyr substrate are well conserved throughout tyrosine-specific phosphatases. However, residues of the peptide that flank the substrate pTyr residue interact with residues of P T P l B that are variable throughout the P T P family, and this finding supports the notion that the interactions between P T P l B and IRK will be specific to this phosphatase-peptide interaction.
KAP-pCDKZ complex
Progression through the cell cycle is co-ordinated by a family of CDKs composed of a protein kinase catalytic subunit and a regulatory cyclin subunit. The principal transitions of the cell cycle are triggered by oscillations of CDK activity, a complex process regulated by reversible protein phosphorylation and controlled synthesis and degradation of activator and inhibitor subunits [12] . The inactive monomeric CDK subunit becomes activated through protein conformational changes accompanied by its association with a specific cyclin molecule and phosphorylation of a conserved and essential threonine residue within the activation segment of the kinase (Thr'" of CDK2). Cyclin degradation and pThr dephosphorylation inactivate the kinase.
Genetic and biochemical studies have implicated KAP as one of the protein phosphatases responsible for dephosphorylating the activating pThr residue of human C D K l , CDK2 and CDK3 [13-161. The enzyme, discovered using a yeast two-hybrid genetic screen as a CDKI-, CDK2-and CDK3-interacting protein [13-151, is ' a member of the DSP family, and is capable of dephosphorylating artificial protein substrates containing both pThr and pTyr residues. KAP associates withCDKl and CDK2invivoandinvitro [15, 16] , and, in HeLa cells, there is evidence that KAP is 0 200 I Biochemical Society 388 present in complexes that include both phosphoand nonphospho-CDK2 and the CDK2-associated cyclins A and E [13] . Recognition that KAP dephosphorylates pThr'" of CDK2 was made by Poon and Hunter [16] , who found that KAP purified either from HeLa cells or from overexpression in Escherichiu coli dephosphorylates the pThr'" residue of monomeric CDK2, but is unable to dephosphorylate pTyr15. Dephosphorylation of pThrlso is dependent upon the tertiary structure of CDK2, a feature that distinguishes KAP from the non-specific PP2A catalytic subunit. Heat-denatured pCDK2 is not a substrate of KAP, and cyclin A association with pCDK2 prevents pThr'" dephosphorylation without blocking pCDK2-KAP interactions. The latter finding suggests that cyclin A controls the accessibility of pThr'" towards KAP, providing a mechanism of phosphatase regulation. The role of KAP in dephosphorylation of the activating pThr residue of pCDK2 explains the observation that overexpression of wild type, but not a catalytically inactive form of, KAP retards cell-cycle progression at G, [13] , and is consistent with the reduced levels of pCDK2 in HEK-293 cells overexpressing KAP [ 161.
In order to understand the mechanism of dephosphorylation of pThr'" of pCDK2 by KAP, and how this activity is modulated by the association of cyclin A, we have determined the crystal structures of KAP and of the pCDK2-KAP complex [ 171. A Michaelis-Menten complex was formed between CDK2 phosphorylated on ThrlB0 and a catalytic site mutant of KAP (Cy~'*~Ser). The essential features of the KAP structure are similar to those of P T P l B [lo] . KAP has a compact structure comprising a central twisted five-stranded b-sheet surrounded by seven a-helices (Figure 2 ). The topology of KAP is almost identical with that of the DSPs VHR (' Vucciniu HI-related phosphatase') [18] and (the catalytic domain of) MKP-3 ['mitogen-activatedprotein kinase (MAPK) phosphatase-3 ' 3 [19] , and represents the core secondary structure of the P T P superfamily. In common with both tyrosinespecific and dual specificity members of the P T P family, the catalytic site is located at the centre of the molecule, with the base of the site formed from the conserved P T P signature motif. The pTyr recognition segment that creates a deep catalytic site cleft specific for pTyr substrates is absent from the smaller DSPs, thereby creating a more open and shallow catalytic-site cleft suitable for the recognition of the shorter pSer and pThr residues (Figure 2) . A structural feature of KAP not seen in other PTPs and DSPs is an eightresidue antiparallel 83/84-hairpin inserted between the 82 strand and a 2 helix. This hairpin structure projects above the surface of the catalytic face of the molecule, and plays a role in forming the pCDK2-KAP interface (Figure 2) .
In the pCDK2-KAP complex, pCDK2 adopts its characteristic ' bilobal ' structure comprising an N-terminal lobe rich in 8-sheet and a Cterminal lobe that is mostly a helical (Figure 2) . T h e catalytic site for A T P is located between the two lobes, whereas that for peptide substrate is associated with the activation segment of the Cterminal lobe. T h e striking feature of the pCDK2-KAP complex is the manner in which KAP interacts with the kinase through an extensive protein-protein interface. KAP is positioned on to the pCDK2 molecule so that the catalytic site of the phosphatase faces towards the catalytic site of the kinase, and critically towards the phosphorylated activation segment (Figure 2) . Interactions between the two proteins involve three distinct recognition sites. First, the catalytic site of KAP recognizes the pThr'" residue from the activation segment of CDK2. T h e activation segment is pulled away from the CDK2 surface in order to make this contact. Secondly, residues from KAP from the C-terminal helix dock on to a site on CDK2 that includes residues from the start of the aG helix (which contains the motif G D S E I D in CDK1, CDK2 and CDK3) and the L14 loop. Thirdly, theP3/84 loop of KAP contacts CDK2 residue Tyr", at the turn between pl and 82 strands of the N-terminal lobe sheet (Figure 2 ). T h e conformation of KAP in the pCDK2-KAP complex is essentially identical with that of the sulphate-liganded molecule. In contrast, the conformation of pCDK2 in the complex differs significantly from that of monomeric pCDK2.
Structure of the pCDK2-KAP interface
T h e only significant interaction between KAP and pCDK2 at the catalytic site is the interaction between the phosphate group of the pThrlso residue of pCDK2 and the PTP loop of KAP. In contrast with the recognition of pTyr-containing peptides by PTPlB, where both the phosphoamino acid itself and its context in the sequence is important in defining the recognition process [10, 11] , KAP activity is not determined by either the identity of the phospho-amino acid or its sequence context. T h e affinity and specificity of the complex between KAP and CDK2 results from interactions at the second recognition site comprising CDK2 residues 205-210 (GDSEID of the aG helix) and 235-237 (DYK of the L14 loop) and a region of KAP that is remote from the catalytic site. The KAP residues from the Cterminal helix, IlelS3 and Tyrlss, dock into a nonpolar pocket formed by the aliphatic groups of the CDK2 residues Leu174, G1uZo8 and Ilezo8. There is a hydrogen bond between the main-chain nitrogen of Ilels3 (KAP) and side chain oxygen of G1uzo8 (CDK2), and salt bridges between LysIs4 (KAP) and Asp235 (CDK2) and between GIu"~ (KAP) and (CDK2). The structural and biochemical results suggest that this interaction site on CDK2 provides the dominant specificity site for recognition of the kinase by KAP. The GDSEID and DYK motifs are conserved in C D K l , CDK2 and CDK3, but not in CDK4 and CDK6. CDK4 does not interact with KAP, as defined by the yeast two-hybrid analysis [13, 15] , and we would also predict the same for CDK6.
Conformational changes of pCDK2
A surprising feature of the KAP-pCDK2 complex is that the conformation of pCDK2 is reminiscent of that of the activated CDK2 structure observed in the CDK2-cyclin A complex [20] . Similar motions of the N-terminal lobe, C-helix and melting of the L12 loop are observed in the two structures. This result suggests that KAP may interact more tightly with CDK2 when associated with cyclin A. The trigger for the conformational changes observed in pCDK2 in the KAP-CDK2 complex appear to originate from the induced unravelling of the kinase-activation segment that results on association of the pThr'" residue at the catalytic site of KAP. In order for KAP to interact with pThr'" of pCDK2, the activation segment is drawn away from the main body of the kinase, with the consequence that the L12 helix at the start of the activation segment is unfolded. Concomitant structural changes in the neighbouring C-helix and B-sheet of the N-terminal lobe result in an activates state of the kinase.
The study of Poon and Hunter [16] demonstrated that KAP-catalysed dephosphorylation of pCDK2 was dependent on the tertiary structure of CDK2. Heat denaturation of CDK2 rendered resistant to dephosphorylation by KAP, presumably because of a disruption of the major CDK2-KAP interface. In addition, it was found that the association of cyclin A with pCDK2 protected pThr'" from dephosphorylation, although intriguingly KAP is capable of associating with the CDK2-cyclin A complex. Our structural results explain these findings. First, the sites on pCDK2 that interact with cyclin A and KAP are essentially non-overlapping, explaining the finding that KAP and cyclin A interact with CDK2 simultaneously (Figure 3 ). In the complex between pCDK2 and cyclin A, the pThr'" residue is sequestered by three arginine residues of pCDK2 (Arg5', ArglZ6 and Arg15'). In the binary complex, these residues are in a position to interact with pThr'" because of the cyclin A-induced shift of the C-helix and activation segment, which directly and indirectly alters the conformation of all three arginine residues. Moreover, the guanidinium side chain of Arg" is stabilized by direct hydrogen bonds to the cyclin A molecule. Degradation of cyclin A mediated by the ubiquitin-proteasome pathway causes a release of the pThr'" residue, as seen in the monomeric pCDK2 structure, to allow the catalytic site of KAP to gain access to the pThr'" residue.
Concluding remarks
Our studies of the structures of the PTPlB-IRK and KAP-pCDK2 complexes [ 10,171 have allowed us to compare and contrast the mechanism of dephosphorylation by a tyrosine-specific phosphatase with that of a DSP. P T P l B employs a catalytic site that selects for pTyr residues and excludes the shorter pSer/pThr residues. T h e conservation of catalytic-site residues of P T P l B throughout the P T P superfamily suggests that all PTPs will catalyse dephosphorylation reactions by a similar mechanism. T h e sequence context of the pTyr residue is also an important determinant of substrate selectivity, achieved by means of interactions involving variable residues of the phosphatase and residues of the peptide that flank the pTyr substrate residue. KAP, an example of a DSP, although employing a similar reaction mechanism, has a catalytic site that would not confer selection for a phospho-amino acid residue. Specificity for the dephosphorylation reaction is provided by interactions between the phosphatase and its kinase substrate that are remote from both the phosphatase's catalytic site and the site of dephosphorylation on the kinase.
